|
Hartley, Craig J; Reddy, Anilkumar K; Madala, Sridhar et al. (2011) Doppler velocity measurements from large and small arteries of mice. Am J Physiol Heart Circ Physiol 301:H269-78
|
|
Garcia-Gras, Eduardo; Lombardi, Raffaella; Giocondo, Michael J et al. (2006) Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy. J Clin Invest 116:2012-21
|
|
Senthil, Vinitha; Chen, Suet N; Tsybouleva, Natalie et al. (2005) Prevention of cardiac hypertrophy by atorvastatin in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circ Res 97:285-92
|
|
Marian, A J (2005) On mice, rabbits, and human heart failure. Circulation 111:2276-9
|
|
Tsybouleva, Natalia; Zhang, Lianfeng; Chen, Suetnee et al. (2004) Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy. Circulation 109:1284-91
|
|
Marian, Ali J (2003) On predictors of sudden cardiac death in hypertrophic cardiomyopathy. J Am Coll Cardiol 41:994-6
|
|
Nagueh, Sherif F; McFalls, Judy; Meyer, Denise et al. (2003) Tissue Doppler imaging predicts the development of hypertrophic cardiomyopathy in subjects with subclinical disease. Circulation 108:395-8
|
|
Marian, A J; Roberts, R (2003) To screen or not is not the question--it is when and how to screen. Circulation 107:2171-4
|
|
Marian, A J (2002) Modifier genes for hypertrophic cardiomyopathy. Curr Opin Cardiol 17:242-52
|
|
Hartley, Craig J; Taffet, George E; Reddy, Anilkumar K et al. (2002) Noninvasive cardiovascular phenotyping in mice. ILAR J 43:147-58
|
Showing the most recent 10 out of 106 publications
